Plytzanopoulou Petrini, Politis Panagiotis, Papachrysanthou Theodora, Andriopoulos Christos, Drakou Athina, Papachristou Evangelos, Papastamatiou Miltiadis, Papasotiriou Marios
Department of Nutrition, ''Konstantopouleio'' General Hospital of Athens, Athens, Greece.
Dialysis Center, ''Nefroiatriki'', Athens, Greece.
Int Urol Nephrol. 2022 Jul;54(7):1565-1573. doi: 10.1007/s11255-021-03032-0. Epub 2021 Oct 21.
Sarcopenia is a clinical condition that comprises declined skeletal muscle (SM) mass and SM strength, and is a risk factor for physical disability, impaired quality of life, and advanced morbidity and mortality in patients on hemodialysis (HD). The existing difficulty in evaluating SM mass and consequently of sarcopenia, with affordable and practical methods in clinical practice, is well established. The purpose of this study is to examine the creatinine index (CrI), a surrogate of SM mass, as a potential predictive marker of sarcopenia.
In this cross-sectional study, we included 130 patients on HD with a mean age of 66.17 ± 12.47 years. SM mass and SM strength were evaluated with CrI and hand grip strength, respectively. Anthropometric, adiposity, nutritional, and biochemical assessments were also performed. Partial correlation and multivariate regression analyses were applied to investigate the association between CrI and SM strength.
Correlation analysis showed that mid-arm circumference, calf circumference, Geriatric nutritional index, and albumin-to-total protein ratio were positively associated with SM strength. Multivariate model indicated that CrI (β = 2.05, p < 0.001) and dialysis duration (β =- 0.53, p = 0.001) were independently related to SM strength. The significant positive correlation between CrI and SM strength remained unaffected even after adjusting for potential confounders.
Creatinine Index was significantly associated with SM strength highlighting its value as a new emerging practical in clinical setting sarcopenia predictive marker in HD patients.
肌肉减少症是一种临床病症,其特征为骨骼肌(SM)质量和力量下降,是血液透析(HD)患者身体残疾、生活质量受损以及晚期发病率和死亡率的危险因素。在临床实践中,使用经济实惠且实用的方法评估SM质量以及由此评估肌肉减少症存在的困难已得到充分证实。本研究的目的是检验作为SM质量替代指标的肌酐指数(CrI),作为肌肉减少症的潜在预测标志物。
在这项横断面研究中,我们纳入了130例HD患者,平均年龄为66.17±12.47岁。分别使用CrI和握力评估SM质量和SM力量。还进行了人体测量、肥胖、营养和生化评估。应用偏相关和多元回归分析来研究CrI与SM力量之间的关联。
相关性分析表明上臂围、小腿围、老年营养指数和白蛋白与总蛋白比值与SM力量呈正相关。多变量模型表明CrI(β = 2.05,p < 0.001)和透析时长(β = -0.53,p = 0.001)与SM力量独立相关。即使在调整潜在混杂因素后,CrI与SM力量之间的显著正相关仍未受影响。
肌酐指数与SM力量显著相关,突出了其作为HD患者临床环境中肌肉减少症预测标志物的新兴实用价值。